Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
The American Journal of Surgical Pathology|July 24, 2025
Clinicopathologic and Molecular Study of TFEB-altered Renal Cell Carcinomas: Tumors With Frequent PDL1 ExpressionMengxin Zhang, Jie Xian, Jiaxiang Tang, et al.
BMC Pulmonary Medicine|December 8, 2022
Effects of airway pressure release ventilation on multi-organ injuries in severe acute respiratory distress syndrome pig modelsAijia Ma, Bo Wang, Jiangli Cheng, et al.
Neoplasia (New York, N.Y.)|August 12, 2019
The Adiponectin-AdipoR1 Axis Mediates Tumor Progression and Tyrosine Kinase Inhibitor Resistance in Metastatic Renal Cell CarcinomaGuangxi Sun, Xingming Zhang, Zhenhua Liu, et al.
The Prostate|January 4, 2024
Utilization trend of prebiopsy multiparametric magnetic resonance imaging and its impact on prostate cancer detection: Real-world insights from a high-volume center in southwest ChinaChichen Zhang, Xiang Tu, Jindong Dai, et al.
The Prostate|August 22, 2019
Does ductal adenocarcinoma of the prostate (DA) have any prognostic impact on patients with de novo metastatic prostate cancer?Tao Wu, Jinge Zhao, Zhenhua Liu, et al.
European Urology Oncology|October 17, 2025
Endoscopic Thulium Laser Ablation with Disitamab Vedotin and Immunotherapy in High-risk Upper Tract Urothelial Carcinoma: A Prospective Pilot Study of a Novel Kidney-sparing StrategyJianjun Ye, Zeyu Chen, Xinyang Liao, et al.
The Prostate|August 26, 2021
The heterogeneity of intraductal carcinoma of the prostate is associated with different efficacy of standard first-line therapy for patients with metastatic castration-resistant prostate cancerZhipeng Wang, Sha Zhu, Jinge Zhao, et al.
The Prostate|July 12, 2019
AKR1C3 expression in primary lesion rebiopsy at the time of metastatic castration-resistant prostate cancer is strongly associated with poor efficacy of abiraterone as a first-line therapyJinge Zhao, Mengni Zhang, Jiandong Liu, et al.
BJU International|June 29, 2021
Circulating tumour DNA reveals genetic traits of patients with intraductal carcinoma of the prostateJinge Zhao, Guangxi Sun, Sha Zhu, et al.
Genome Medicine|May 2, 2023
Genomic and transcriptomic features between primary and paired metastatic fumarate hydratase-deficient renal cell carcinomaJiayu Liang, Guangxi Sun, Xiuyi Pan, et al.
Pageof 8